ASX - By Stock
|
KPO |
Re:
Ann: Non-Renounceable Entitlement Offer Results
|
|
standalone
|
6 |
598 |
0 |
12:10 |
12:10 |
ASX - By Stock
|
6
|
598
|
0
|
|
ASX - By Stock
|
KPO |
Re:
Ann: Non-Renounceable Entitlement Offer Results
|
|
standalone
|
6 |
598 |
0 |
11:16 |
11:16 |
ASX - By Stock
|
6
|
598
|
0
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Kidney Disease Drug Candidate Progressing to Human Trials
|
|
standalone
|
28 |
7.7K |
1 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
28
|
7.7K
|
1
|
|
ASX - By Stock
|
PPL Technology |
Re:
A message to the Board of Directors
|
|
standalone
|
12 |
4.2K |
2 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
12
|
4.2K
|
2
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Kidney Disease Drug Candidate Progressing to Human Trials
|
|
standalone
|
28 |
7.7K |
0 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
28
|
7.7K
|
0
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
standalone
|
255 |
109K |
1 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
255
|
109K
|
1
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
standalone
|
255 |
109K |
0 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
255
|
109K
|
0
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
standalone
|
255 |
109K |
2 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
255
|
109K
|
2
|
|
ASX - By Stock
|
PYC |
Re:
PYC Filed Another Patent
|
|
standalone
|
15 |
9.6K |
1 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
15
|
9.6K
|
1
|
|
ASX - By Stock
|
PYC Biotech |
Re:
PYC Chart and Technical Analysis
|
|
standalone
|
106 |
43K |
8 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
106
|
43K
|
8
|
|
ASX - By Stock
|
KPO |
Re:
Ann: Clarification Announcement
|
|
standalone
|
2 |
854 |
1 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
2
|
854
|
1
|
|
ASX - By Stock
|
PYC |
Re:
PYC Filed Another Patent
|
|
standalone
|
15 |
9.6K |
10 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
15
|
9.6K
|
10
|
|
ASX - By Stock
|
PYC |
Re:
PYC Filed Another Patent
|
|
standalone
|
15 |
9.6K |
3 |
25/03/24 |
25/03/24 |
ASX - By Stock
|
15
|
9.6K
|
3
|
|
ASX - By Stock
|
PPL |
Re:
Ann: H1 FY24 Results Presentation
|
|
standalone
|
15 |
5.3K |
4 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
15
|
5.3K
|
4
|
|
ASX - By Stock
|
PPL |
Re:
Ann: H1 FY24 Results Presentation
|
|
standalone
|
15 |
5.3K |
3 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
15
|
5.3K
|
3
|
|
ASX - By Stock
|
PYC |
Re:
Ann: PYC Equity Raising to Raise up to $74.6 Million
|
|
standalone
|
19 |
8.9K |
3 |
16/03/24 |
16/03/24 |
ASX - By Stock
|
19
|
8.9K
|
3
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Trading Halt
|
|
standalone
|
12 |
4.5K |
3 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
12
|
4.5K
|
3
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
standalone
|
255 |
109K |
0 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
255
|
109K
|
0
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
standalone
|
255 |
109K |
2 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
255
|
109K
|
2
|
|
ASX - By Stock
|
KPO |
Re:
Ann: Half Yearly Report and Accounts
|
|
standalone
|
19 |
4.2K |
0 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
19
|
4.2K
|
0
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
standalone
|
255 |
109K |
0 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
255
|
109K
|
0
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
standalone
|
255 |
109K |
1 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
255
|
109K
|
1
|
|
ASX - By Stock
|
PPL |
Re:
Ann: H1 FY24 Results Presentation
|
|
standalone
|
15 |
5.3K |
5 |
06/03/24 |
06/03/24 |
ASX - By Stock
|
15
|
5.3K
|
5
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
standalone
|
255 |
109K |
3 |
06/03/24 |
06/03/24 |
ASX - By Stock
|
255
|
109K
|
3
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
standalone
|
255 |
109K |
0 |
06/03/24 |
06/03/24 |
ASX - By Stock
|
255
|
109K
|
0
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
standalone
|
255 |
109K |
11 |
06/03/24 |
06/03/24 |
ASX - By Stock
|
255
|
109K
|
11
|
|
ASX - By Stock
|
PPL |
Re:
Ann: H1 FY24 Results Presentation
|
|
standalone
|
15 |
5.3K |
8 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
15
|
5.3K
|
8
|
|
ASX - By Stock
|
KPO |
Re:
Ann: Regulatory & Project Development Update
|
|
standalone
|
93 |
24K |
2 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
93
|
24K
|
2
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
standalone
|
255 |
109K |
1 |
23/02/24 |
23/02/24 |
ASX - By Stock
|
255
|
109K
|
1
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
standalone
|
255 |
109K |
2 |
23/02/24 |
23/02/24 |
ASX - By Stock
|
255
|
109K
|
2
|
|
ASX - By Stock
|
PYC Biotech |
Re:
PYC Chart and Technical Analysis
|
|
standalone
|
106 |
43K |
9 |
19/02/24 |
19/02/24 |
ASX - By Stock
|
106
|
43K
|
9
|
|
ASX - By Stock
|
PYC Biotech |
Re:
PYC Chart and Technical Analysis
|
|
standalone
|
106 |
43K |
4 |
19/02/24 |
19/02/24 |
ASX - By Stock
|
106
|
43K
|
4
|
|
ASX - By Stock
|
PPL |
Re:
Ann: Q2 FY24 - Record half-year group revenue of $24m for H1 FY24
|
|
standalone
|
22 |
8.3K |
5 |
17/02/24 |
17/02/24 |
ASX - By Stock
|
22
|
8.3K
|
5
|
|
ASX - By Stock
|
STK |
Re:
Stk General
|
|
standalone
|
924 |
311K |
1 |
16/02/24 |
16/02/24 |
ASX - By Stock
|
924
|
311K
|
1
|
|
ASX - By Stock
|
PYC Biotech |
Re:
PYC Chart and Technical Analysis
|
|
standalone
|
106 |
43K |
2 |
15/02/24 |
15/02/24 |
ASX - By Stock
|
106
|
43K
|
2
|
|
ASX - By Stock
|
PYC Biotech |
Re:
PYC Chart and Technical Analysis
|
|
standalone
|
106 |
43K |
2 |
14/02/24 |
14/02/24 |
ASX - By Stock
|
106
|
43K
|
2
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Q1 2024 Investor Webinar Presentation
|
|
standalone
|
10 |
4.3K |
7 |
03/02/24 |
03/02/24 |
ASX - By Stock
|
10
|
4.3K
|
7
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
standalone
|
255 |
109K |
1 |
01/02/24 |
01/02/24 |
ASX - By Stock
|
255
|
109K
|
1
|
|
ASX - By Stock
|
KPO |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
standalone
|
8 |
2.6K |
1 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
8
|
2.6K
|
1
|
|
ASX - By Stock
|
VTX |
Re:
Ann: Trading Halt
|
|
standalone
|
2 |
648 |
1 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
2
|
648
|
1
|
|
ASX - By Stock
|
PPL |
Re:
Ann: Q2 FY24 - Record half-year group revenue of $24m for H1 FY24
|
|
standalone
|
22 |
8.3K |
5 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
22
|
8.3K
|
5
|
|
ASX - By Stock
|
PPL |
Re:
Ann: Q2 FY24 - Record half-year group revenue of $24m for H1 FY24
|
|
standalone
|
22 |
8.3K |
3 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
22
|
8.3K
|
3
|
|
ASX - By Stock
|
KPO |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
standalone
|
8 |
2.6K |
3 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
8
|
2.6K
|
3
|
|
ASX - By Stock
|
PPL |
Re:
Ann: Q2 FY24 - Record half-year group revenue of $24m for H1 FY24
|
|
standalone
|
22 |
8.3K |
3 |
30/01/24 |
30/01/24 |
ASX - By Stock
|
22
|
8.3K
|
3
|
|
ASX - By Stock
|
KPO |
Re:
Ann: Regulatory & Project Development Update
|
|
standalone
|
93 |
24K |
4 |
30/01/24 |
30/01/24 |
ASX - By Stock
|
93
|
24K
|
4
|
|
ASX - By Stock
|
PPL |
Re:
Ann: Q2 FY24 - Record half-year group revenue of $24m for H1 FY24
|
|
standalone
|
22 |
8.3K |
1 |
30/01/24 |
30/01/24 |
ASX - By Stock
|
22
|
8.3K
|
1
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
standalone
|
14 |
5.1K |
2 |
25/01/24 |
25/01/24 |
ASX - By Stock
|
14
|
5.1K
|
2
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
standalone
|
255 |
109K |
1 |
24/01/24 |
24/01/24 |
ASX - By Stock
|
255
|
109K
|
1
|
|
ASX - By Stock
|
PYC Biotech |
Re:
PYC Chart and Technical Analysis
|
|
standalone
|
106 |
43K |
1 |
22/01/24 |
22/01/24 |
ASX - By Stock
|
106
|
43K
|
1
|
|
ASX - By Stock
|
PYC |
Re:
Ann: AI Driven Drug Discovery Collaboration with Google Cloud
|
|
standalone
|
41 |
17K |
1 |
17/01/24 |
17/01/24 |
ASX - By Stock
|
41
|
17K
|
1
|
|